

Medical Affairs and Governance manager with 15+ years of experience in healthcare system across GCC and Egypt, driving scientific excellence, cross-functional influence, and practice-changing initiatives across GCC. Known for elevating medical strategy, strengthening governance frameworks, and enabling launch readiness in CVRM. A trusted partner with a proven record in KEE engagement, formulary inclusions success, evidence-driven decision making, and the ability to influence without authority. Brings a unique blend of scientific depth, enterprise leadership, and governance mastery, enabling impactful medical contributions that enhance patient outcomes and position AstraZeneca as a scientific leader.
Supported the strong performance of Dapagliflozin, with impactful contribution in the successful launch of CKD and HF across Gulf. Worked closely with the CFT to support the disease area within CVRM and the preparation for CKD launch in UAE, Lokelma launch and Andexxa pre-launch in UAE.